[ 177 Lu]Lu-DOTA-TATE and [ 131 I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Grupos
Abstract
The aim of the study is to assess phenotypic imaging patterns and the response to treatment with [ 177 Lu]Lu-DOTA-TATE and/or [ 131 I]MIBG in paragangliomas (PGLs) and pheochromocytomas (PHEOs), globally and according to the primary location.
Copyright © 2022 Prado-Wohlwend, del Olmo-García, Bello-Arques and Merino-Torres.
Datos de la publicación
- ISSN/ISSNe:
- 1664-2392, 1664-2392
- Tipo:
- Article
- Páginas:
- 778322-778322
- PubMed:
- 35197929
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,375 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Frontiers in Endocrinology FRONTIERS MEDIA SA
Citas Recibidas en Web of Science: 15
Documentos
- No hay documentos
Filiaciones
Keywords
- PRRT, [131I]MIBG, [177Lu]Lu-DOTA-TATE, [68Ga]Ga-DOTA-TOC, paraganglioma, phenotypic imaging, pheochromocytoma
Cita
PRADO S,DEL OLMO MI,BELLO P,MERINO JF. [ 177 Lu]Lu-DOTA-TATE and [ 131 I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center. Front. Endocrinol. 2022. 13. p. 778322-778322. IF:5,200. (1).
Portal de investigación